搜索筛选:
搜索耗时4.1167秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
发布年度:
[期刊论文] 作者：Zhong-Zhen Guan,Jian-Ming Xu,R,
来源：癌症：英文版 年份：2011
...
[期刊论文] 作者：Zhong-Zhen Guan,Jian-Ming Xu,R,
来源：黑龙江科技学院学报 年份：2011
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
A PHASE I CLINICAL TRIAL OF NOVEL ANTICANCER DRUG DICYCLOPLATIN IN PATIENTS WITH ADVANCED SOLID MALI
[会议论文] 作者：Xu-qing Yang,Zhen-yun Yang,Wei-Chuan Cui,Chang-nian Liu,Zhong-zhen Guan,Su Li,
来源：第67届世界药学大会(67th International Conference of FIP) 年份：2007
...
A PHASE I CLINICAL TRIAL OF NOVEL ANTICANCER DRUG DICYCLOPLATIN IN PATIENTS WITH ADVANCED SOLID MALI
[会议论文] 作者：Xu-qing Yang,Zhong-zhen Guan,Su Li,Zhen-yun Yang,Wei-Chuan Cui,Chang-nian Liu,
来源：第67届世界药学大会(67th International Conference of FIP) 年份：2007
...
Lapatinib (L) Plus Paclitaxel (P) as First-Line Therapy in Chinese Patients With HER2-Overexpressing
[会议论文] 作者：Bing-he Xu,Zhong-zhen Guan,Michelle DeSilvio,Mark Russo,Zhen-zhou Shen,Zhong-shen Tong,Ze-fei Jiang,Jun-lan,
来源：第十四届全国临床肿瘤学大会暨2011年CSCO学术年会 年份：2011
...
Lapatinib (L) Plus Paclitaxel (P) as First-Line Therapy in Chinese Patients With HER2-Overexpressing
[会议论文] 作者：Bing-he Xu,Zhong-zhen Guan,Michelle DeSilvio,Zhen-zhou Shen,Zhong-shen Tong,Ze-fei Jiang,Jun-lan Yang,
来源：第十四届全国临床肿瘤学大会暨2011年CSCO学术年会 年份：2011
Objective: The recently completed phase Ⅲ randomized, double-blind EGF104535 study compared lapatinib plus paclitaxel (L+P) versus placebo+P in patients with HER2-positive (MBC).As previously reported...
Expression of BAFF-R but not BAFF as an independent prognostic factor for diffusing large B-cell lym
[会议论文] 作者：Yu Wang,Wen-Qi Jiang,Ya-Jun Li,Zhi-Ming Li,Jia-Jia Huang,Yi Xia,Hui-Qiang Huang,Tong-Yu Lin,Zhong-Zhen Guan,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Efficacy and safety of pegaspargase with gemcitabine and oxaliplatin in patients with treatment-naiv
[会议论文] 作者：Yan Gao,Zhong-Zhen Guan,Xiao-Xiao Wang,Bing Bai,Wei Zhao,wen-Qi Jiang,Hui-Qiang Huang,Qing-Qing Cai,Qi-Chun,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Expression of BAFF-R but not BAFF as an independent prognostic factor for diffusing large B-cell lym
[会议论文] 作者：Wen-Qi Jiang,Ya-Jun Li,Zhi-Ming Li,Hui-Lan Rao,Jia-Jia Huang,Yi Xia,Hui-Qiang Huang,Tong-Yu Lin,Zhong-Zhen Guan,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: B-cell activation factor (BAFF) and BAFF-receptor(BAFF-R) play crucial roles in the survival and proliferation of malignant B-cells.Limited information exists on the expression profiles and...
Efficacy and safety of pegaspargase with gemcitabine and oxaliplatin in patients with treatment-naiv
[会议论文] 作者：Yan Gao,Zhong-Zhen Guan,Hui-Qiang Huang,Qi-Chun Cai,Xiao-Xiao Wang,Qing-Qing Cai,Zhong-Jun Xia,Bing Bai,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: Extranodal natural killer/T-cell lymphoma(ENKTL) is an aggressive form of non-Hodgkins lymphoma with poor prognosis.The response rate to pegaspargase(PEG-ASP)-based multi-agent regimens is...
相关搜索：
